The objective is to compare a reduced stent strategy based on drug-coated balloon (DCB) percutaneous coronary intervention (PCI) with conventional drug-eluting stent (DES) coronary revascularization in patients presenting with ST-segment myocardial infarction (STEMI).
Randomization will be performed after successful culprit-lesion guidewire crossing and flow restoration. Random allocation in a 1:1 fashion to one of the following strategies:
* Study group: reduced stent PCI strategy (DCB-based) * Control group: conventional PCI strategy (DES-based).
None
Life expectancy <1 year due 1 to non-cardiac disease.
Inability to provide informed consent.
Cardiogenic shock.
Left ventricular ejection fraction <15%.
Parallel
Primary PCI
DeviceCoronary percutaneous revascularization
Target lesion failure (TLF)
Target-vessel myocardial infarction or ischemia-driven target-lesion revascularization
Incidence of all-cause death
Physicians Assessment
Incidence of myocardial infarction
Physicians Assessment
Incidence of cardiovascular death
Physicians Assessment
Incidence of target lesion revascularization
Physicians Assessment
Click on the lead sponsor to view all of their trials.
Hospital Universitario La Fe
Lead sponsor
ERA4Health
Collaborator
